4//SEC Filing
Waheed Nadia 4
Accession 0001104659-25-055981
CIK 0001393434other
Filed
Jun 2, 8:00 PM ET
Accepted
Jun 3, 4:20 PM ET
Size
5.7 KB
Accession
0001104659-25-055981
Insider Transaction Report
Form 4
Waheed Nadia
Chief Medical Officer
Transactions
- Sale
Common Stock
2025-06-02$8.05/sh−13,861$111,581→ 206,805 total
Footnotes (2)
- [F1]Represents shares of common stock of Ocular Therapeutix, Inc. (the "Corporation") sold, pursuant to a durable automatic sale instruction adopted by the reporting person on June 1, 2024, effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations in connection with the vesting of restricted stock units on June 1, 2025. The sales do not represent a discretionary trade by the reporting person.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.94 to $8.16, inclusive. The reporting person undertakes to provide to the Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.
Documents
Issuer
OCULAR THERAPEUTIX, INC
CIK 0001393434
Entity typeother
Related Parties
1- filerCIK 0002023884
Filing Metadata
- Form type
- 4
- Filed
- Jun 2, 8:00 PM ET
- Accepted
- Jun 3, 4:20 PM ET
- Size
- 5.7 KB